Medigen Joins Taiwan-Australia Biotech& Pharma Exchange Hosted by the Australian Office in Taipei

2026/04/23
Dr. Stanley Chang, Chairman of Medigen, was honored to be invited by Mr. Robert Fergusson, Representative of the Australian Office in Taipei, to attend the Taiwan-Australia Biotech& Pharma Exchange Luncheon held on April 21st.

Figure 1: Mr. Robert Fergusson (Representative of the Australian Office in Taipei), Professor Sharon Lewin, and Chairman Stanley Chang during the exchange luncheon.
 
The event featured Professor Sharon Lewin, Director of the Peter Doherty Institute for Infection and Immunity in Australia. Professor Lewin is a globally recognized expert in infection and immunity research, with significant contributions to infectious diseases and public health. During the luncheon, Chairman Chang and Professor Lewin engaged in an in-depth exchange regarding the field of immunology.

Medigen Biomedical Group is privileged to have participated in this exchange. We will continue to deepen cooperation between Taiwan and Australia, jointly promoting innovation in the biotech sector to provide better solutions for disease treatment.

Figure 2: Professor Sharon Lewin (left) and Chairman Stanley Chang (right) engaging in discussion and posing for a photo.